Matches in Wikidata for { <http://www.wikidata.org/entity/Q82726144> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q82726144 description "article scientifique publié en 2011" @default.
- Q82726144 description "artículu científicu espublizáu en payares de 2011" @default.
- Q82726144 description "im November 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82726144 description "scientific article published on 30 November 2011" @default.
- Q82726144 description "wetenschappelijk artikel" @default.
- Q82726144 description "наукова стаття, опублікована в листопаді 2011" @default.
- Q82726144 name "Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis" @default.
- Q82726144 name "Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis" @default.
- Q82726144 type Item @default.
- Q82726144 label "Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis" @default.
- Q82726144 label "Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis" @default.
- Q82726144 prefLabel "Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis" @default.
- Q82726144 prefLabel "Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis" @default.
- Q82726144 P1433 Q82726144-15C9F4AD-6043-4093-8C93-F9E70F23960C @default.
- Q82726144 P1476 Q82726144-7933E02B-FA24-4E9B-9CC8-2E45A3A026A8 @default.
- Q82726144 P2093 Q82726144-37E2349F-FF3B-4CAE-A78C-9BFE7282E793 @default.
- Q82726144 P2093 Q82726144-3DC385BD-3E70-4920-A502-F0F7B211645C @default.
- Q82726144 P2093 Q82726144-6A50E5E3-9040-4CC9-AE19-59EF9F48F0FD @default.
- Q82726144 P2093 Q82726144-F8863985-9FAB-411E-83FE-F6686B91905D @default.
- Q82726144 P304 Q82726144-B85997D0-C30C-492F-AB68-37399672BBDD @default.
- Q82726144 P31 Q82726144-E1FBF042-E16C-4C46-988D-48E90AF74452 @default.
- Q82726144 P356 Q82726144-CE8383E8-600D-4E30-B0DB-4619454F9AF9 @default.
- Q82726144 P433 Q82726144-E0C3977A-C5A8-4088-B91E-F550FF7E564F @default.
- Q82726144 P478 Q82726144-1BBB593B-8C74-4997-ADED-51A437BA3C75 @default.
- Q82726144 P577 Q82726144-DB8EFCD0-A774-4312-B664-505E55C8F956 @default.
- Q82726144 P698 Q82726144-8924AB69-E501-4F9C-925A-737E87E4E2C6 @default.
- Q82726144 P921 Q82726144-A951242A-4308-4B3F-BF9A-5B40DD8BA7D6 @default.
- Q82726144 P356 J.1468-3083.2011.04357.X @default.
- Q82726144 P698 22126264 @default.
- Q82726144 P1433 Q15760872 @default.
- Q82726144 P1476 "Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis" @default.
- Q82726144 P2093 "A García" @default.
- Q82726144 P2093 "A J Blasco" @default.
- Q82726144 P2093 "C Ferrándiz" @default.
- Q82726144 P2093 "P Lázaro" @default.
- Q82726144 P304 "768-777" @default.
- Q82726144 P31 Q13442814 @default.
- Q82726144 P356 "10.1111/J.1468-3083.2011.04357.X" @default.
- Q82726144 P433 "6" @default.
- Q82726144 P478 "26" @default.
- Q82726144 P577 "2011-11-30T00:00:00Z" @default.
- Q82726144 P698 "22126264" @default.
- Q82726144 P921 Q10355321 @default.